Evidence map›Paper›PMID 37780983›Full record

ArticleFrontiers in chemistry2023

Redox/pH-responsive hollow manganese dioxide nanoparticles for thyroid cancer treatment.

Jinren Liu, Changzhi Guo, Chunxiang Li, Qiushi Jia, Zhengrong Xie, Ziyue Wang, Hongda Tian, Zhongyuan Li, Liguo Hao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Responsive nanomaterials in biomedicine, patent path and prospect analysis.Frontiers in bioengineering and biotechnology · 2025
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 4 countries.

Jinren LiuDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Changzhi GuoDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Chunxiang LiDepartment of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, China.
Qiushi JiaDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Zhengrong XieDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Ziyue WangDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Hongda TianDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Zhongyuan LiDepartment of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, China.
Liguo HaoDepartment of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar, China.
Qiqihar Medical University · CNIntel (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nano drug delivery system MnO

Indexed as

cisplatinenhanced permeability and retention effecthollow manganese dioxidemagnetic resonance imagingnano drug delivery system

Identifiers

PMID37780983
PMCPMC10540626
OpenAlexW4386837638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.